Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma.
Joanne E KavanaghAndrew P HearnGrainne d'AnconaJaideep DhariwalCris RoxasLinda GreenLouise ThomsonMariana FernandesBrian Daniel KentAlexandra M NanzerAlexandra M NanzerPublished in: Allergy (2020)